![Jean-Manasse Theagene](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : - $ au 30/06/2026
Jean-Manasse Theagene is the founder of 360Medlink, Inc. since 2010, holding the title of President & Chief Executive Officer.
Mr. Theagene is currently an Independent Director at MAIA Biotechnology, Inc. since 2023.
Education includes undergraduate and graduate degrees from the University of Montréal and an MBA from HEC Montréal.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 17/03/2023 |
360Medlink, Inc.
 360Medlink, Inc. Packaged SoftwareTechnology Services Provides digital therapeutics, virtual health and clinical research solutions for treatment & clinical trial management | Directeur Général | 01/11/2010 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HEC Montréal
 HEC Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
360Medlink, Inc.
360Medlink, Inc. Packaged SoftwareTechnology Services Provides digital therapeutics, virtual health and clinical research solutions for treatment & clinical trial management | Technology Services |
MAIA Biotechnology, Inc.
 MAIA Biotechnology, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops cancer therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
